{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cardiotoxicity and Breast Cancer as Late Effects of Pediatric and Adolescent Hodgkin Lymphoma Treatment

Purpose of Activity

To provide information about the late adverse effects of both the historical and current management of pediatric and adolescent Hodgkin lymphoma (HL).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. recognize late adverse effects associated with the historical and current management of pediatric and adolescent HL.
  2. identify appropriate observation and screening guidelines for the development of late adverse treatment effects throughout the lifespan of these patients.
Price: $27.95

Credits:

  • ANCC 3.0 CH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH
  • GA - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.







Test Code: AJN0416B
Published: Apr 2016
Expires: 3/6/2020
Passing Score: 13/18 (72%)
Authors: Joanne Lee Candela, MPH, ANP
Specialties: Oncology, Pediatrics